-
1201
-
1202
-
1203
Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
Published 2025-01-01Get full text
Article -
1204
-
1205
-
1206
-
1207
-
1208
Neuroprotective Actions of Cannabinoids in the Bovine Isolated Retina: Role of Hydrogen Sulfide
Published 2025-01-01Get full text
Article -
1209
-
1210
-
1211
-
1212
-
1213
-
1214
Antimicrobial Stewardship in Acute Care Centres: A Survey of 68 Hospitals in Quebec
Published 2008-01-01Get full text
Article -
1215
Evaluation of In Vitro Anti-inflammatory Activity of Azomethines of Aryl Oxazoles
Published 2011-01-01Get full text
Article -
1216
Inferior Vena Cava and Renal Vein Thrombosis Associated with Thymic Carcinoma
Published 2017-01-01Get full text
Article -
1217
-
1218
Resveratrol—A Promising Therapeutic Agent with Problematic Properties
Published 2025-01-01“…The biological properties of resveratrol, in particular antioxidant, anti-inflammatory, anticancer, estrogenic, vasorelaxant and cardioprotective activity, are the main reason for its importance in medicine and pharmacy. Despite all of its advantages, however, there are many problems related to this polyphenolic substance, such as low stability, water insolubility, poor bioavailability and fast metabolism. …”
Get full text
Article -
1219
-
1220
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
Published 2025-12-01Get full text
Article